Last reviewed · How we verify

NCT03425864

PES After Soft Tissue Augmentation Using CTG Around Immediate Dental Implants Versus Immediate Dental Implants Alone in Esthetic Zone

Completed NA Last updated 18 June 2021
What this trial tests

NA trial testing connective tissue graft in Soft Tissue Augmentation in 3 participants. Completed in 13 October 2020.

Timeline
11 July 2017
Primary endpoint
13 September 2020
13 October 2020

Quick facts

Lead sponsorNada Farouk Hasan Abd El-Aziz
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment3
Start date11 July 2017
Primary completion13 September 2020
Estimated completion13 October 2020
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Nada Farouk Hasan Abd El-Aziz

Who can join

Adults 20 to 50, any sex, with Soft Tissue Augmentation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of the present study is to compare the esthetic result and stability of gingival tissue over the immediate implant only and immediate implant with connective tissue in patients with single non-restorable tooth in the esthetic zone. The main null hypothesis to be tested is that the addition of SCTG to immediately placed implants will not significantly differ from immediately placed implant alone as regard gingival tissue stability.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of connective tissue graft

Trials testing the same drug.

Other recruiting trials for Soft Tissue Augmentation

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03425864.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing